Natixis Advisors
INSM icon

Natixis Advisors’s Insmed INSM Stock Holding History

Natixis Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.85M Buy
73,607
+30,673
+71% +$3.71M 0.01% 796
2026
Q1 		$7.02M Buy
42,934
+5,766
+16% +$886K 0.01% 755
2025
Q4 		$6.47M Sell
37,168
-2,282
-6% -$416K 0.01% 749
2025
Q3 		$5.68M Buy
39,450
+3,991
+11% +$489K 0.01% 806
2025
Q2 		$3.57M Buy
35,459
+5,597
+19% +$428K 0.01% 900
2025
Q1 		$2.28M Buy
29,862
+8,537
+40% +$653K ﹤0.01% 1038
2024
Q4 		$1.47M Buy
21,325
+431
+2% +$31K ﹤0.01% 1189
2024
Q3 		$1.52M Buy
+20,894
New +$1.54M ﹤0.01% 1174

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Natixis Advisors's INSM Position: Q2 2026 in Review

Natixis Advisors increased its Insmed (INSM) stake by 71% in Q2 2026, buying an estimated $3.71M and bringing the position to 73,607 shares worth $7.85M. The position accounts for 0.01% of the portfolio, ranked #796.

Natixis Advisors first reported a position in INSM in Q3 2024 and has held it in 8 quarters since. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Natixis Advisors held 73,607 shares of Insmed worth $7.85M as of Q2 2026.
  • Natixis Advisors bought 30,673 Insmed shares in Q2 2026, an estimated $3.71M.
  • Insmed made up 0.01% of Natixis Advisors's portfolio in Q2 2026, its #796 holding.
  • Natixis Advisors first reported a position in Insmed in Q3 2024 and has held it in 8 quarters since.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Natixis Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.